Share on StockTwits
 

Smith & Nephew (LON: SN) received a number of price target changes and ratings updates during the last week:

  • Smith & Nephew was upgraded by analysts at UBS AG to a “buy” rating. They now have a GBX 1,000 ($16.43) price target on the stock, up previously from GBX 780 ($12.82).
  • Smith & Nephew had its “hold” rating reaffirmed by analysts at Berenberg Bank. They now have a GBX 920 ($15.12) price target on the stock.
  • Smith & Nephew had its “neutral” rating reaffirmed by analysts at Citigroup Inc.. They now have a GBX 870 ($14.30) price target on the stock.
  • Smith & Nephew had its “neutral” rating reaffirmed by analysts at JPMorgan Chase & Co..
  • Smith & Nephew had its “sell” rating reaffirmed by analysts at Societe Generale. They now have a GBX 660 ($10.85) price target on the stock.
  • Smith & Nephew had its “hold” rating reaffirmed by analysts at Panmure Gordon. They now have a GBX 720 ($11.83) price target on the stock.
  • Smith & Nephew had its “add” rating reaffirmed by analysts at Numis Securities Ltd. They now have a GBX 1,000 ($16.43) price target on the stock, up previously from GBX 960 ($15.78).
  • Smith & Nephew had its “buy” rating reaffirmed by analysts at UBS AG. They now have a GBX 1,000 ($16.43) price target on the stock.
  • Smith & Nephew had its “equal weight” rating reaffirmed by analysts at Barclays. They now have a GBX 780 ($12.82) price target on the stock.
  • Smith & Nephew had its “sell” rating reaffirmed by analysts at Goldman Sachs Group Inc..
  • Smith & Nephew had its “hold” rating reaffirmed by analysts at Deutsche Bank. They now have a GBX 650 ($10.68) price target on the stock.

Shares of Smith & Nephew (LON:SN) traded up 0.06% during mid-day trading on Wednesday, hitting GBX 874.50. 2,098,075 shares of the company’s stock traded hands. Smith & Nephew has a 1-year low of GBX 692.592 and a 1-year high of GBX 897.00. The stock has a 50-day moving average of GBX 869.8 and a 200-day moving average of GBX 810.. The company’s market cap is £7.862 billion.

Smith & Nephew plc is a global medical devices business operating in the markets for orthopaedic reconstruction and trauma, endoscopy (Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.